Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for t... Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant for the treatment of respiratory disease, disorder, or condition in humans; Rostafuroxin, which is in Phase 2b clinical trials for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activators, which are in preclinical trials for the treatment of chronic and acute heart failure. In addition, it is developing an aPKCi inhibitor, which is in preclinical trials for the treatment of cutaneous malignancies and solid tumors. Windtree Therapeutics, Inc. has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of a portfolio of potential KL4 surfactant products; a license, development, and commercialization agreement with Lee’s Pharmaceutical (HK) Ltd. and Zhaoke Pharmaceutical (Hefei) Co. Ltd.; a license agreement with Philip Morris USA, Inc. and Johnson & Johnson; and a collaboration with Battelle Memorial Institute for the development of its aerosol delivery system. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0016 | 12.5 | 0.0128 | 0.0179 | 0.0121 | 59131 | 0.01488087 | CS |
| 4 | -0.0056 | -28 | 0.02 | 0.0225 | 0.01 | 123327 | 0.01605288 | CS |
| 12 | 0.0054 | 60 | 0.009 | 0.034 | 0.009 | 340742 | 0.01537726 | CS |
| 26 | -0.0465 | -76.354679803 | 0.0609 | 0.065 | 0.007135 | 346395 | 0.01909511 | CS |
| 52 | -7.7356 | -99.8141935484 | 7.75 | 7.75 | 0.007135 | 418019 | 0.05939019 | CS |
| 156 | -7.7356 | -99.8141935484 | 7.75 | 7.75 | 0.007135 | 405844 | 0.05939019 | CS |
| 260 | -7.7356 | -99.8141935484 | 7.75 | 7.75 | 0.007135 | 394358 | 0.05939019 | CS |
rakp
10分前
Ridetherocket
13分前
DLEtest
21分前
Genz2
31分前
big bopper1
43分前
John543
47分前
satter
1時間前
JimBoStevens
1時間前
WandererGolem241
1時間前
ExoticSuccess1582
1時間前
nwsun
1時間前
ChangnoiPlaza
1時間前
Lolo_Ferrari
2時間前
mdb1
2時間前
Genz2
2時間前
georgejjl
2時間前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。